Atlas Trials

Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis

Clinical trial NCT00275379 · WITHDRAWN

Trial details

NCT number
NCT00275379
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Cystitis, Interstitial
Start date
2006-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.